Graypoint LLC Ocular Therapeutix, Inc Transaction History
Graypoint LLC
- $1.56 Billion
- Q1 2025
A detailed history of Graypoint LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Graypoint LLC holds 20,194 shares of OCUL stock, worth $143,579. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,194Holding current value
$143,579% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$102 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$98.7 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$90.7 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$81.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$59.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $547M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...